Tubulointerstitial Nephritis Antigen-Like 1 (TINAGL1) (Middle Region) Peptid
Kurzübersicht für Tubulointerstitial Nephritis Antigen-Like 1 (TINAGL1) (Middle Region) Peptid (ABIN8114971)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Verwendungszweck
- TINAGL1 Peptide - middle region
-
Sequenz
- ENGPVQALME VHEDFFLYKG GIYSHTPVSL GRPERYRRHG THSVKITGWG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-TINAGL1 Antibody(ARP57622_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- TINAGL1 (Tubulointerstitial Nephritis Antigen-Like 1 (TINAGL1))
-
Hintergrund
-
Background Information: TINAGL1 may be implicated in the adrenocortical zonation and in mechanisms for repressing the CYP11B1 gene expression in adrenocortical cells. This is a non catalytic peptidase C1 family protein.
Alternative Symbols: ARG1, LCN7, LIECG3, TINAGRP
-
Molekulargewicht
- 52kDa
-
Gen-ID
- 64129
-
NCBI Accession
- NP_071447
-
UniProt
- Q9GZM7
Target
-